Medical devices, healthcare technology and the business of care
510(k) clearance · K254188

Meniscus Versaflex

GM Dos Reis Industria e Comercio Ltda. · Decision date Feb 19, 2026

FDA DECISIONK254188

What did the FDA decide?

FDA records K254188 as a 510(k) premarket notification, with a decision dated Feb 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Feb 19, 2026

FDA source record

Regulatory record facts

Identifier
K254188
Regulatory pathway
510(k) premarket notification
Product code
GAT
Decision code
SESE
Decision date
Feb 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Suture, Nonabsorbable, Synthetic, Polyethylene.

Product code
GAT
FDA device class
2

FDA decision timeline

  1. K254188 received

    Application receipt date recorded by FDA.

  2. K254188 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GAT

Product / regulatory recordCompanyPathwayDecision dateSource
GM Dos Reis Industria e Comercio Ltda.510(k) clearanceAug 22, 2026FDA
Winter Innovations, Inc.510(k) clearanceJul 1, 2026FDA
Teleflex Medical LLC510(k) clearanceMay 6, 2026FDA
Threadstone, LLC510(k) clearanceMar 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GM Dos Reis Industria e Comercio Ltda.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Campinas

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records